For the Inventor, By the Inventor

Enter assignee name

Watertown, MA, United States of America

Boston Biomedical Research Institute

USPTO Granted Patents = 29

Forward Citations = 492

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Victor A Raso (10 out of 11 patents)

Henry P Paulus (5 out of 6 patents)

Ruben Rene Gonzalez (3 out of 3 patents)

4. Paul C Leavis (3 out of 11 patents)

5. Bernard Jacobson (3 out of 3 patents)

6. Peter F Davison (2 out of 2 patents)

7. Sigmund A Weitzman (2 out of 4 patents)

8. Philip J Graceffa (2 out of 2 patents)

9. Katherine Sheldon (2 out of 2 patents)

10. James L Sherley (1 out of 9 patents)

11. Charles P Emerson, Jr (1 out of 1 patent)

12. Xingbin Ai (1 out of 1 patent)

13. Peter Erhardt (1 out of 1 patent)

14. Ambrus Toth (1 out of 1 patent)

15. Wei-Jen Tang (1 out of 2 patents)

29 patents: Sort by Forward Citations

1. 8759098 - Method for cloning pluripotent stem cells (2014-06-24),

2. 8058228 - Leptin peptide antagonists (2011-11-15),

3. 7968527 - Inhibition of FGF signaling (2011-06-28),

4. 7906626 - Immunological control of β-amyloid levels in vivo (2011-03-15),

5. 7749966 - Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity (2010-07-06),

6. 7709216 - Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death (2010-05-04),

7. 7612043 - Method of reducing or inhibiting ObR signaling using a leptin antagonist consisting of SEQ id No: 2 (2009-11-03),

8. 7553832 - Methods and compositions for specific inhibition of protein splicing by small molecules (2009-06-30),

9. 7462472 - Methods and compositions relating to anthrax pathogenesis (2008-12-09),

10. 7413884 - Immunological control of β-amyloid levels in vivo (2008-08-19),

11. 7407929 - Leptin peptide antagonists (2008-08-05),

12. 6872554 - Immunological control of β-amyloid levels in vivo (2005-03-29),

13. 6582945 - Immunological control of &bgr;-amyloid levels in vivo (2003-06-24),

14. 6140091 - Anti-idiotype vaccines to elicit catalytic antibodies (2000-10-31),

15. 5830478 - Method for delivering functional domains of diphtheria toxin to a (1998-11-03),

The Boston Biomedical Research Institute (BBRI) is a non-profit biomedical research organization located in Boston, Massachusetts. Established in 1985, BBRI is dedicated to advancing knowledge and finding new treatments for a wide range of diseases through cutting-edge research and collaborations with academic and industry partners. With a team of highly skilled scientists and state-of-the-art facilities, BBRI focuses on cancer research, neurobiology, and molecular biology. Through their innovative research efforts, BBRI aims to improve human health and contribute to the development of new therapeutics and diagnostic tools.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

29 Patents

#16 in Watertown, MA

#667 in Massachusetts

#11,219 in US

#21,844 in the World

Watertown, MA, United States of America

Boston Biomedical Research Institute

Forward Citations = 492

18 inventors:

Victor A Raso (10 out of 11 patents)

Henry P Paulus (5 out of 6 patents)

Ruben Rene Gonzalez (3 out of 3 patents)

4. Paul C Leavis (3 out of 11 patents)

5. Bernard Jacobson (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…